Subtype
Large Intestinal Neoplasm
CI-CAN-00001062Explore in graph →
Non-malignant1,847 active trials21 approved drugs383 evidence items
- NCIt
- C215201
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001062Explore in graph →
Clinical trials
8,849 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02770911 | Laparoscopic Anterior Resection With or Without "Dog Ear" Double-stapled Anastomosis for Rectal Cancer | unknown | Phase 3 | 250 | Fujian Medical UniversityOTHER | 0 | May 12, 2016 | clinicaltrials |
| NCT00603577 | Role of Xaliproden on Recovery Rate From Severe Neuropathy in Patients Who Have Completed Adjuvant Chemotherapy With Oxaliplatin Based Regimens(XENON) | terminated | Phase 3 | 102 | SanofiINDUSTRY | 8 | May 5, 2016 |
| clinicaltrials |
| NCT00305188 | Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy. | completed | Phase 3 | 879 | SanofiINDUSTRY | 13 | May 4, 2016 | clinicaltrials |
| NCT02748772 | Application of Two Anti-angiogenesis Drugs Combined With Chemotherapy in Advanced Colorectal Cancer Under the Background of Precision Medical | unknown | Phase 3 | 148 | The First People's Hospital of HefeiOTHER | 1 | Apr 22, 2016 | clinicaltrials |
| NCT02744274 | Efficacy of Acupuncture in Prevention of Chemotherapy Induced Peripheral Neuropathy - a Pilot Study | unknown | Phase 3 | 32 | Tzu-Liang ChenOTHER | 1 | Apr 21, 2016 | clinicaltrials |
| NCT00000611 | Women's Health Initiative (WHI) | completed | Phase 3 | — | National Heart, Lung, and Blood Institute (NHLBI)NIH | 0 | Apr 15, 2016 | clinicaltrials |
| NCT02727153 | "Ultra" Enhanced Recovery After Surgery (E.R.A.S.) in Laparoscopic Colectomy for Cancer | completed | Phase 3 | 765 | AUSL Romagna RiminiOTHER | 0 | Apr 5, 2016 | clinicaltrials |
| NCT00069108 | A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 627 | Hoffmann-La RocheINDUSTRY | 20 | Apr 1, 2016 | clinicaltrials |
| NCT00058474 | Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer | unknown | Phase 3 | 1,608 | NSABP Foundation IncNETWORK | 0 | Mar 23, 2016 | clinicaltrials |
| NCT00813540 | The Effects of Exercise Training on the Health-related Fitness of Colon Cancer Survivors | completed | Phase 2 / Phase 3 | 52 | AHS Cancer Control AlbertaOTHER | 1 | Mar 11, 2016 | clinicaltrials |
| NCT00123760 | Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer | completed | Phase 2 / Phase 3 | 10,838 | AHS Cancer Control AlbertaOTHER | 1 | Feb 25, 2016 | clinicaltrials |
| NCT01584830 | Asian Subjects With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy(CONCUR) | completed | Phase 3 | 204 | BayerINDUSTRY | 5 | Feb 8, 2016 | clinicaltrials |
| NCT00305643 | Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer | terminated | Phase 3 | 11 | M.D. Anderson Cancer CenterOTHER | 2 | Dec 24, 2015 | clinicaltrials |
| NCT00265824 | Optimized Chemotherapy Followed by Maintenance With Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Colorectal Cancer That Cannot be Removed by Surgery (DREAM)(DREAM) | completed | Phase 3 | 700 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 3 | Dec 11, 2015 | clinicaltrials |
| NCT02598414 | The Role of Indocyanine Green (ICG) Fluorescence Imaging on Anastomotic Leak in Robotic Colorectal Surgery | unknown | Phase 2 / Phase 3 | 102 | Acibadem UniversityOTHER | 1 | Nov 24, 2015 | clinicaltrials |
| NCT02607072 | Aspirin for Prevention of Postsurgical Recurrence and Metastasis in Asian Colorectal Cancer Patients: a Multi-center Randomized Trial(APREMEC) | unknown | Phase 3 | 3,000 | The Fourth Affiliated Hospital of Anhui Medical UniversityOTHER | 1 | Nov 18, 2015 | clinicaltrials |
| NCT00075868 | Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer | completed | Phase 3 | 233 | Radiation Therapy Oncology GroupNETWORK | 1 | Nov 17, 2015 | clinicaltrials |
| NCT02350166 | Short-term Effects of LASI Surgery Versus Conventional Laparotomy for Colorectal Liver Metastasis | unknown | Phase 3 | 40 | West China HospitalOTHER | 1 | Nov 17, 2015 | clinicaltrials |
| NCT00085163 | Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon | completed | Phase 3 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Oct 20, 2015 | clinicaltrials |
| NCT02024412 | Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX 6 in mCRC | unknown | Phase 3 | 240 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Sep 28, 2015 | clinicaltrials |
| NCT02548403 | Effect of Simethicone on Bowel Preparation for Colonoscopy | completed | Phase 3 | 260 | Korea University Anam HospitalOTHER | 1 | Sep 14, 2015 | clinicaltrials |
| NCT00973609 | Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC) | completed | Phase 3 | 853 | AIO-Studien-gGmbHOTHER | 1 | Sep 1, 2015 | clinicaltrials |
| NCT01483443 | Oophorectomy Followed by Chemotherapy Versus Chemotherapy Alone in Colorectal Cancer Patients | completed | Phase 3 | 140 | Gachon University Gil Medical CenterOTHER | 1 | Sep 1, 2015 | clinicaltrials |
| NCT00440310 | Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases | completed | Phase 3 | 483 | Light Sciences OncologyINDUSTRY | 13 | Aug 25, 2015 | clinicaltrials |
| NCT00188305 | A Randomized Trial of Cancer Risk and Health Education in Relatives of Colorectal Cancer Patients | completed | Phase 3 | 252 | University Health Network, TorontoOTHER | 1 | Aug 17, 2015 | clinicaltrials |
| NCT00126256 | Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal Cancer | completed | Phase 3 | 570 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Aug 13, 2015 | clinicaltrials |
| NCT02510118 | Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients | unknown | Phase 2 / Phase 3 | 360 | Nanjing NingQi Medicine Science and Technology Co., Ltd.INDUSTRY | 1 | Aug 3, 2015 | clinicaltrials |
| NCT00700102 | A Study of Avastin (Bevacizumab) Plus Crossover Fluoropyrimidine-Based Chemotherapy in Patients With Metastatic Colorectal Cancer. | completed | Phase 3 | 820 | Hoffmann-La RocheINDUSTRY | 15 | Jul 30, 2015 | clinicaltrials |
| NCT02503150 | Trial of Antigen Pulsed Dendritic Cells (APDC) in Metastatic Colorectal Cancer | unknown | Phase 3 | 480 | Second Military Medical UniversityOTHER | 0 | Jul 30, 2015 | clinicaltrials |
| NCT01030042 | Trial Comparing Two Two Sequences of Therapy in Colorectal Metastatic Patients(COMETS) | completed | Phase 3 | 110 | Gruppo Italiano per lo studio dei Carcinomi dell'Apparato DigerenteOTHER | 1 | Jul 15, 2015 | clinicaltrials |
| NCT01103323 | Patients With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy | completed | Phase 3 | 760 | BayerINDUSTRY | 19 | Jun 24, 2015 | clinicaltrials |
| NCT00396487 | Tailored Treatment in Metastatic Colorectal Cancer | terminated | Phase 3 | 1 | Vejle HospitalOTHER | 1 | Jun 11, 2015 | clinicaltrials |
| NCT00735241 | FOLFOX6 Plus Sir-Spheres Microspheres Plus Avastin in Patients With Nonresectable Liver Metastases From Colorectal Carcinoma(FAST) | withdrawn | Phase 2 / Phase 3 | 0 | Sirtex MedicalINDUSTRY | 1 | May 22, 2015 | clinicaltrials |
| NCT01211210 | Neoadjuvant FOLFOX6 Chemotherapy With or Without Radiation in Rectal Cancer(FOWARC) | unknown | Phase 2 / Phase 3 | 495 | Sun Yat-sen UniversityOTHER | 1 | May 22, 2015 | clinicaltrials |
| NCT01103479 | Low-Literacy Physician-Patient Intervention Promoting Colorectal Cancer Screening | completed | Phase 2 / Phase 3 | 569 | Northwestern UniversityOTHER | 1 | May 6, 2015 | clinicaltrials |
| NCT01814969 | Preoperative Hyperfractionated Radiotherapy or Radiochemotherapy in Locally Advanced Rectal Cancer. | unknown | Phase 3 | 260 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | May 5, 2015 | clinicaltrials |
| NCT01290783 | Trial of FOLF(HA)Iri Versus FOLFIRI in mCRC(FOLF(HA)iri) | unknown | Phase 3 | 390 | Alchemia OncologyINDUSTRY | 1 | Apr 29, 2015 | clinicaltrials |
| NCT02419677 | Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases | completed | Phase 2 / Phase 3 | 60 | The First People's Hospital of ChangzhouOTHER | 1 | Apr 17, 2015 | clinicaltrials |
| NCT02415699 | DC-CIK Immunotherapy Plus Chemotherapy vs Chemotherapy Alone in the Adjuvant Treatment of Stage III Colorectal Cancer | unknown | Phase 2 / Phase 3 | 100 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 0 | Apr 14, 2015 | clinicaltrials |
| NCT01229813 | Avastin and Chemotherapy Followed by a KRAS Stratified Randomization to Maintenance Treatment for First Line Treatment of Metastatic Colorectal Cancer.(ACT2) | completed | Phase 3 | 233 | Lund University HospitalOTHER | 2 | Apr 13, 2015 | clinicaltrials |
| NCT02402972 | A Multi-center Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer | unknown | Phase 3 | 700 | Xu jianminOTHER | 1 | Mar 31, 2015 | clinicaltrials |
| NCT00457691 | Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 768 | PfizerINDUSTRY | 34 | Mar 30, 2015 | clinicaltrials |
| NCT02399059 | Effect of Peritoneal Lavage With Clindamycin-Gentamicin Solution & Oncologic Outcome | completed | Phase 3 | 106 | Hospital General Universitario ElcheOTHER | 0 | Mar 26, 2015 | clinicaltrials |
| NCT00782457 | Prospective Randomised Study Comparing Laparoscopic Versus Open Surgery in Patients With Rectal Cancer | completed | Phase 3 | 200 | Hospital Universitario Virgen de la ArrixacaOTHER | 0 | Mar 18, 2015 | clinicaltrials |
| NCT00719797 | Combination Chemotherapy and Bevacizumab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer(TRIBE) | completed | Phase 3 | 509 | Gruppo Oncologico del Nord-OvestOTHER | 1 | Mar 11, 2015 | clinicaltrials |
| NCT00720512 | Second-Line Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Who Have Received First-Line Chemotherapy and Bevacizumab(BEBYP) | terminated | Phase 3 | 184 | Gruppo Oncologico del Nord-OvestOTHER | 1 | Mar 11, 2015 | clinicaltrials |
| NCT01219920 | FOLFOXIRI Compared With FOLFIRI for Metastatic Colorectal Cancer | completed | Phase 3 | 244 | Gruppo Oncologico del Nord-OvestOTHER | 1 | Mar 11, 2015 | clinicaltrials |
| NCT01423214 | A Trial to Assess Robot-assisted Surgery and Laparoscopy-assisted Surgery in Patients With Mid or Low Rectal Cancer(COLRAR) | unknown | Phase 3 | 540 | Kyungpook National University HospitalOTHER | 1 | Mar 11, 2015 | clinicaltrials |
| NCT00484939 | A Study of Bevacizumab (Avastin) in Combination With Capecitabine (Xeloda) in Elderly Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 280 | Hoffmann-La RocheINDUSTRY | 12 | Jan 8, 2015 | clinicaltrials |
| NCT00646607 | FOLFOX-4 3months Versus 6 Months and Bevacizumab as Adjuvant Therapy for Patients With Stage II/III Colon Cancer(TOSCA) | completed | Phase 3 | 3,756 | Gruppo Italiano per lo studio dei Carcinomi dell'Apparato DigerenteOTHER | 1 | Nov 26, 2014 | clinicaltrials |
Data updated 23 days agoSource updated May 12, 2016source: clinicaltrials